Hope for new drug to fight liver cancer
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Liver, Liver Cancer, Liver Cancer, Liver Disease, News & EventsPrimary liver cancer is a deadly illness and one of the fastest growing cancer types in the world. Now researchers from the Harry Perkins Institute of Medical Research have developed…
New discovery for treatment of primary liver cancer shows promise
By Richard Schoonraad | Cancer, Cancer, Cancer Epigenetics, Disease Area, Epigenetics and Genomics Laboratory, Lab, Liver, Liver Cancer, Liver Cancer, Liver Disease, Mitochondrial Medicine and Biology, News & Events, ResearchA study using preclinical models has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer…
Perkins secures biobanking grants to answer important questions in future research
By Alicia Bienkowski | awards, Cancer, Cancer, Cancer Epigenetics, Centre for Diabetes Research, Diabetes, Diabetes, Funding, Inspiration, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Translational OncologyThe McGowan Government recently announced that the Harry Perkins Institute will receive two of the 16 grants totalling more than $1.5 million to support Western Australian biobanks. Congratulations to both…
NHMRC funding for DEFINER to identify “the right drug for the right patient” in liver cancer
By Alicia Bienkowski | awards, Cancer, Cancer, Funding, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, xOncofetal EcosystemThe Harry Perkins Institute's Oncofetal Ecosystem Laboratory, established early in 2021, has received its first NHMRC Ideas Grant in the most recent grants round. This collaborative project run by the…